While the mechanism surrounding the lack of cancer specificity effect was not elucidated within our investigation, this does suggest that other Lem-D proteins may be more suited candidates as cancer therapeutics than TMPO, as there may be a heightened risk of toxicity to normal cells with this target. The gene discussed is TMPO; the disease is cancer.